Dana Yaacov-Garbeli
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dana Yaacov-Garbeli
Dana Yaacov-Garbeli is recorded as CFO at Entera Bio Ltd. (ENTX). Entera Bio Ltd. reported in an 8-K filed July 18, 2022 that Dana Yaacov-Garbeli was appointed Chief Financial Officer (principal financial officer), effective July 15, 2022. The proxy statement of Entera Bio Ltd. reports total compensation of $438 for Dana Yaacov-Garbeli in fiscal 2024, including a base salary of $226. Disclosed compensation is on record for 3 fiscal years.
“On July 13, 2022, the Board appointed Dana Yaacov-Garbeli, who is the Company’s Israel-based Chief Financial Officer and principal accounting officer, to serve as the Company’s Chief Financial Officer (principal financial officer) effective on July 15, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Entera Bio Ltd.
Other people whose current roles at this company are on record from its filings.
- Miranda Toledano CEO, Board Member
- Geno J. Germano Chairman, Board Member
- Steven D. Rubin Chairman, Board Member
- Yonatan Malca Chairman
- Hillel Galitzer COO
- Geno H. Germano Board Member
- Haya Taitel Board Member
- Laura Hamill Board Member
- Sean Ellis Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Entera Bio Ltd. (ENTX) | Chief Finance Officer | $226 | $438 |
| 2023 | Entera Bio Ltd. (ENTX) | Chief Finance Officer | $193 | $311 |
| 2022 | Entera Bio Ltd. (ENTX) | Chief Finance Officer | $193 | $381 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.